Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

14 May 2014 14:25

RNS Number : 1238H
Maven Income & Growth VCT 4 PLC
14 May 2014
 

Maven Income and Growth VCT 4 PLC

Result of Annual General Meeting

 

At the Annual General Meeting of the Company held at 10.30 am at Fifth Floor, 1-2 Royal Exchange Buildings, London, EC3V 3LF on 14 May 2014, all of the Resolutions put to the Meeting were duly passed.

 

At the record date for the Annual General Meeting, being 9 May 2014, the total number of voting rights in the Company stood at 29,168,273 Ordinary Shares and 3,863,876 C Ordinary Shares. The total shares in issue were 33,032,149. In accordance with the provisions of D.2.2 of the Combined Code on Corporate Governance, the Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 4,168,737 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Annual Report and audited Financial Statements

3,845,883

267,044

13,368

42,442

4,168,737

2

To approve the Directors' Remuneration Report

3,713,289

270,682

118,106

66,660

4,168,737

3

To approve the Directors' remuneration policy

3,686,517

275,176

130,361

76,683

4,168,737

4

To approve a final dividend

3,899,516

266,146

3,075

0

4,168,737

5

To re-elect Mr D Potter as a Director

3,616,057

266,429

241,976

44,275

4,168,737

6

To re-elect Mr A Lapping as a Director

3,573,521

265,815

280,838

48,563

4,168,737

7

To re-elect Mr S Scott as a Director

3,558,663

268,905

282,924

58,245

4,168,737

8

To re-elect Mr W Nixon as a Director

3,719,921

303,290

107,187

38,339

4,168,737

9

To appoint Deloitte LLP as Auditor

 

3,804,656

291,643

54,485

17,953

4,168,737

10

To authorise the Directors to fix the remuneration of the Auditor

3,787,608

349,893

13,382

17,854

4,168,737

11

To authorise the Directors to allot new shares

3,825,280

296,485

30,899

16,073

4,168,737

12

To authorise disapplication of pre-emption rights

3,461,906

294,870

344,264

67,697

4,168,737

13

To authorise the Company to purchase its own shares

3,089,902

294,965

773,997

9,873

4,168,737

14

To allow a General Meeting to be called on not less than 14 days' notice

3,685,574

300,705

126,815

55,643

4,168,737

 

 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. The voting figures will be available to view at: www.mavencp.com/migvct4.

 

Passing of Resolutions under Special Business

 

The Special Resolutions have been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.//hemscott.com/nsm.do.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

14 May 2014

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGBXGDUXDBBGSS
Date   Source Headline
1st May 202410:08 amRNSIssue of Equity
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:48 pmRNSIssue of Equity
27th Mar 202410:39 amRNSIssue of Equity
25th Mar 202410:14 amRNSStatement re Offer for Subscription
19th Mar 20245:03 pmRNSTransaction in Own Shares
20th Feb 20242:48 pmRNSDividend Declaration
8th Feb 202410:33 amRNSDirector/PDMR Shareholding
8th Feb 202410:10 amRNSIssue of Equity
17th Jan 202410:03 amRNSDirector/PDMR Shareholding
17th Jan 202410:02 amRNSDirector/PDMR Shareholding
17th Jan 20249:58 amRNSIssue of Equity
15th Jan 20244:28 pmRNSUnaudited Net Value Asset
15th Nov 20235:06 pmRNSTransaction in Own Shares
9th Nov 20233:53 pmRNSNet Asset Value(s)
9th Nov 20233:49 pmRNSResult of General Meeting
13th Oct 20234:56 pmRNSPublication of a Prospectus
13th Oct 202310:17 amRNSDirector/PDMR Shareholding
13th Oct 202310:15 amRNSIssue of Equity - Dividend Investment Scheme
6th Oct 20232:39 pmRNSStatement re Dividend Investment Scheme
8th Sep 20235:01 pmRNSTransaction in Own Shares-Corrective announcement
7th Sep 20233:35 pmRNSTransaction in Own Shares
30th Aug 20232:02 pmRNSHalf-year Report
17th Aug 20233:26 pmRNSStatement re NAV and Interim Dividend
12th Jul 20234:09 pmRNSHolding(s) in Company
10th Jul 20235:06 pmRNSHolding(s) in Company
2nd Jun 202310:05 amRNSDirector/PDMR Shareholding
2nd Jun 20239:43 amRNSIssue of Equity
24th May 20235:10 pmRNSTransaction in Own Shares
23rd May 202310:18 amRNSDirector/PDMR Shareholding
23rd May 202310:17 amRNSIssue of Equity - Dividend Investment Scheme
12th May 20233:38 pmRNSNet Asset Value(s) - Dividend Investment Scheme
11th May 20233:01 pmRNSResult of AGM
11th May 20232:20 pmRNSNet Asset Value(s)
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
13th Apr 20237:00 amRNSAnnual Financial Report
5th Apr 202312:36 pmRNSDirector/PDMR Shareholding
5th Apr 202312:30 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
21st Mar 20234:08 pmRNSTransaction in Own Shares
3rd Mar 20239:56 amRNSIssue of Equity
21st Feb 20234:11 pmRNSUnaudited NAV and Proposed Final Dividend
21st Feb 20233:10 pmRNSUnaudited Net Asset Value, Proposed Final Dividend
16th Feb 20237:00 amRNSStatement re Offer for Subscription
8th Feb 202310:24 amRNSDirector/PDMR Shareholding
8th Feb 202310:17 amRNSDirector/PDMR Shareholding
8th Feb 20239:44 amRNSIssue of Equity
3rd Feb 20233:12 pmRNSProvisional Net Asset Value
23rd Nov 20224:53 pmRNSTransaction in Own Shares
10th Nov 20223:33 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.